Vizianagaram, India

Guptha Chinni Guru Deva

This inventor holds 1 USPTO granted patent. Top assignee: Shilpa Medicare Limited. Active years: 2020.


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guptha Chinni Guru Deva: Innovator in Pharmaceutical Formulations

Introduction

Guptha Chinni Guru Deva is a notable inventor based in Vizianagaram, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable formulations. His innovative work has the potential to enhance the efficacy and stability of important medications.

Latest Patents

Guptha holds a patent for a "Stable melphalan liquid injectable formulation." This invention relates to a stable, non-aqueous liquid formulation consisting essentially of melphalan, or a pharmaceutical acceptable salt thereof. The formulation includes one or more solvents selected from a group consisting of dimethyl acetamide, polyethylene glycol, ethanol, propylene glycol, dimethyl sulfoxide, N-methylpyrrolidone, and glycerol. Notably, this formulation is free of antioxidants, organic acids, and added chloride ions, which is crucial for maintaining the stability of the drug.

Career Highlights

Guptha is currently associated with Shilpa Medicare Limited, a company known for its focus on pharmaceutical innovations. His work at the company has allowed him to explore and develop new formulations that can significantly impact patient care.

Collaborations

Guptha has collaborated with talented individuals such as Shivakumar Pradeep and Rizwan Ahmed. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Guptha Chinni Guru Deva is a prominent figure in the pharmaceutical industry, with a focus on innovative injectable formulations. His contributions, particularly in the area of stable melphalan formulations, highlight his commitment to improving healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…